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Summary PCR-based microsatellite polymorphisms have proved their power in genetic linkage analysis and
other identification methods, due to their high information content and even distribution over the
chromosomes. In the present study we applied microsatellite polymorphisms to detect loss of heterozygosity in
fresh (snap-frozen) and in archival ovarian tumour tissue. Clear allele losses were found in fresh and paraffin
embedded tumour samples. Conventional Southern analysis of flanking markers on the same tumour DNA
samples confirmed the observed losses detected by microsatellite polymorphisms.
Titration experiments suggest that loss of heterozygosity remains detectable in tumour samples despite 60%
contamination with normal DNA. This technique provides a fast and reproducible alternative to conventional
Southern blotting in the detection of loss of heterozygosity, with the crucial additional advantages of minimal
sample requirements, making archival material available for genetic investigation.
The loss of genetic material from specific chromosomal loca-
tions in a given tumour type has been taken as evidence for
the involvement of tumour suppressor genes in the genesis of
these tumours (Ponder, 1988; Cavenee et al., 1983; Vogelstein
et al., 1988). Demonstration of such losses often relies on the
use of DNA probes for the detection of polymorphisms
(RFLP/VNTR) on Southern blots of restriction enzyme
digested cellular DNA (Caskey, 1987). In patients constitu-
tionally heterozygous for a polymorphic marker, loss of
heterozygosity (LOH) or allelic imbalance is observed as a
complete or partial signal reduction of one of the two corre-
sponding alleles in the matching tumour DNA. Southern
blotting is often limited by the availability of sufficient
amounts of normal or tumour DNA and by the low infor-
mativeness of conventional RFLP markers.
The introduction of the polymerase chain reaction (PCR)
(Saiki et al., 1988) provided an entirely new means of analys-
ing genetic polymorphisms (Saiki et al., 1985), especially of
the microsatellite type (Weber & May, 1989; Smeets et al.,
1985). The number of alleles found at these loci ranges from
four to more than ten. A maximum heterozygosity of 0.99
makes them much more informative than standard two-allele
RFLP markers (maximum heterozygosity 0.50); in addition
they are evenly distributed over the genome.
In this study the application of microsatellite polymor-
phisms to detect LOH in fresh as well as in formalin fixed,
paraffin embedded ovarian tumour tissue was investigated.
The observed LOH events were corroborated by Southern
analysis with flanking markers. Titration experiments show
that LOH is relatively insensitive to the number of PCR
cycles and is still detectable in a contaminating background
of 60% normal DNA.
Materials and methods
DNA extraction
Genomic DNA, isolated from freshly collected peripheral
blood leucocytes (Miller et al., 1988) served as matching
normal DNA in the LOH studies and as template DNA in
the titration experiments.
Fresh tissue from two serous adenocarcinomas of the
ovary was immediately snap-frozen after surgery in cold
isopentane and stored at - 70°C. For isolation of genomic
DNA, 40 gim sections of frozen material were processed as
previously described (Devilee et al., 1989). From the same
tumours, DNA was extracted from formalin fixed, paraffin
embedded tissue. Also included were paraffin blocks of an
endometrioid carcinoma and of a poorly differentiated
adenocarcinoma from a patient treated in 1983. The percent-
age of tumour cells was estimated by visual examination of
haematoxylin and eosin stained 5 ;m thick sections. Blocks
with a high content of tumour cells (80%) were selected.
Control DNA was obtained from paraffin blocks containing
normal tissue from the same patient. Paraffin embedded tis-
sue, fixed in phosphate-buffered formalin (4%), was cut in
10 Lm thick sections. Three consecutive sections were placed
in a 1.5 ml Eppendorf tube and deparaffinised essentially as
described by Shibata et al. (1988) and Wright and Manos
(1990) with slight modifications. After washing twice (30min)
with 1 ml of xylene (J.T. Baker, Phillipsburg, NJ), tissue
sections were pelleted and the supernatant was decanted.
Residues of xylene were removed by washing twice with
absolute ethanol. The pellets were rinsed with 2-3 drops of
acetone at 65°C to remove the last traces of ethanol.
The pellets were digested overnight at 370C with
0.3 pgm11 proteinase K (Boehringer) in 100 gl 10 mM
Tris.HCI, pH 8.3, 1 mM EDTA and 0.5% Tween 20
(Limpens et al. submitted). Proteinase K was heat-inactivated
by boiling the samples for 7 min. After centrifugation, 2 slI
aliquots of the supernatant were subjected to PCR.
Quantitation ofthe DNA concentration
Aliquots of 2 yl DNA solution were denatured by the addi-
tion of 20 gil 0.4 M NaOH, 20 mM EDTA and dot-blotted on
a Hybond N + nylon filter (Amersham) which was pre-
incubated for 10min in the same denaturing solution. The
filter was dried for 2 h (800C) and cross-linked with UV light
for 2 min. The amount of DNA was visually estimated after
hybridisation with BLUR8, an Alu-repeat containing probe
(Deininger & Schmid, 1979), performed as described by
Church and Gilbert (1984). As standard a series of known
DNA concentrations (O.1-1000 ng per spot) was used.
Polymorphism analysis
In the Southern analysis the following RFLP markers were
used: D17S58 (EW301) (Barker et al., 1987a), D17S4
(THH59) (Barker et al., 1987b) and D17S74 (CMM86)
(Toguchida et al., 1989). These markers detect several alleles
of 1.4-4.5, 0.8-1.8 kb and 1.0-3.5kb respectively and are
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known to frequently show LOH in ovarian cancer (Foulkes
et al., 1991). They flank the microsatellite markers 46E6
(Skolnick, personal communication), D17S588 (42D6) and
THRAl used in this study. The primer-pair to detect 46E6 is
5'-TTCATGGGGCTTACTGTGTTC and 5'-TAGCACTC-
TGCCTTCCAACATAC. In addition, D6S251 (mfdl3l) and
D3S1238 (mfdl25) were used in the titration experiments.
Primer sequences and allele frequencies of these markers,
THRAI and 42D6 may be retrieved from the Genome Data
Base.
The relative intensity of the polymorphic fragments
obtained by Southern analysis (RFLP markers) or PCR
(microsatellites) was estimated by visual inspection or
quantified by laser densitometry (LKB 2202 Ultrascan laser
densitometer). The imbalance factor is defined as the ratio of
allele intensities in the tumour sample relative to the ratio of
the alleles in normal DNA. For example an imbalance factor
of 2.50 is expected in a tumour with allele loss in all tumour
cells and containing 40% non-malignant cells (1.0:0.4 in
tumour vs 1.0:1.0 in lymphocyte DNA). A factor of 1.3 or
lower was considered inconclusive (Devilee et al., 1991).
PCR conditions
PCR amplification reactions were performed essentially as
described by Weber and May (1989). PCR reaction mixtures
contained 2f.l purified template DNA, 10 mM Tris.HCl,
pH9.0; 1.5mM MgCl2; 50mM KCl; 0.01% gelatin; 0.1%
Triton X-100; 200 ,LM each dGTP, dTTP, dATP; 2.5 f4M
dCTP; 0.75 yiCi [&2P]dCTP (3000 Ci mmolh , 10 JLCi .tLI'),
3.0 pmol of each PCR primer and 0.06 U Super Taq
(Sphaero Q, HT Biotechnology LTD) in a total volume of
15pl.
Samples were covered with mineral oil, denatured for
5 min at 94°C and passed through 33 cycles of amplification
consisting of 1 min denaturation at 94°C, 2min primer
annealing at 55°C, 1 min elongation at 72°C followed by a
final cycle with an extension of 6 min at 72°C. The
amplifications were carried out in a 96 well microtiter dish
using a thermal cycler (MJ Research, Watertown, MA,
USA). After PCR, samples were denatured with two volumes
of 0.3% xylene-cyanol; 0.3% bromphenol blue; 10 mM
EDTA pH 8.0; 90% (v/v) formamide and subjected to elect-
rophoresis on a 0.4 mm-thick 6.5% polyacrylamide gel con-
taining 7 M urea. After fixation and drying, the gel was
exposed to X-ray film.
Results
Titration experiments
Allele losses in surgically removed tumour tissue are often
incomplete, since the tissue often contains a certain amount
of normal cells, derived from stromal components or
infiltrating lymphocytes. In these cases a residual signal is
a
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Figure 1 a, Allelic imbalance was simulated by mixing a total of 15 ng DNA from individuals I and II in the ratios 0:10 (lane 1),
0.5:9.5 (lane 2), 1.0:9.0 (lane 3), 1.5:8.5 (lane 4), 2.0:8.0 (lane 5), 2.5:7.5 (lane 6), 3.0:7.0 (lane 7), 3.5:6.5 (lane 8), 4.0:6.0 (lane 9),
4.5:5.5 (lane 10) and 5.0:5.0 (lane 11). PCR was performed with D3S1238. With this marker person I is homozygous for allele 2,
and person II is heterozygous (1,2). Exposure was overnight. b, Results from densitometry scanning after 28 cycles of amplification
(right panels). The lines enclose the area scanned by the densitometer (left panels).
Table I Expected and observed imbalance factors obtained in a simulation of
LOH
Lane 1 2 3 4 5 6 7 8 9 10 11
Exp co 19.0 9.0 5.7 4.0 3.0 2.3 1.9 1.5 1.2 1.0
Obsa 25 11.8 5.5 3.8 2.4 1.9 1.9 1.8 1.5 1.1 1.0
aThe imbalance factor is defined as the ratio of allele intensities in the tumour
sample relative to the ratio of the alleles in normal DNA (Figure 1b; lane 11).310 N.A. GRUIS et al.
observed at the postion of the lost allele. In an attempt to
simulate incomplete LOH, we performed a titration experi-
ment by mixing genomic DNA from an individual I, being
homozygous (2/2) for D3S1238, with increasing amounts of
DNA from a heterozygous (1/2) individual II. Thus, the
DNA from individual I mimics DNA from a tumour from
individual II in which allele 1 is lost by somatic recombina-
tion. PCR amplification was performed on a total of 15 ng
input DNA of each ratio for 28 cycles (Figure la). Thus lane
2 mimics the situation in which a tumour is contaminated
with 10% normal cells. The signal for the 'contaminating'
allele 1 proportionally increased with the amount of normal
heterozygous DNA in the mixtures. The intensity difference
between alleles 1 and 2 remain clearly visible at least up to
lane 7. This would suggest that an allelic imbalance would
still be detectable in a tumour with 60% non-malignant
contamination. Figure lb shows the quantitation of the
alleles. Intensities of the bands in the indicated windows were
scanned by laser densitometry. Imbalance factors were cal-
culated according to the definition described in the Materials
and methods section. Results obtained by this experiment are
shown in Table I. As expected from the predicted values, the
decrease of the imbalance factor parallels the increasing
percentages of contaminating DNA, although there is no
absolute correspondence between the observed and expected
data.
In addition, the effect of the number of PCR cycles was
investigated. This was ofinterest because it is known that the
yield of PCR products is only proportional to the amount of
input DNA template when the amplification remains within
the exponential range of the PCR reaction. If not so,
differences in the initial concentrations of the alleles will be
compensated (Noonan et al., 1990). The behaviour of the
PCR products was studied by mixing DNA from two indi-
viduals, I and II, both homozygous for two different alleles
of D6S251. DNA was diluted serially according to the ratios
indicated in Figure 2a. The total amount of DNA in each
sample was again 15 ng. Samples were amplified for 28, 33
and 36 cycles respectively. Signal intensity differences due to
different ratios of input DNA are clearly visible and remain
stable during increasing numbers of amplification cycles.
Figure 2b shows the quantitation of the allelic imbalance
obtained after 28 cycles. There is a good agreement between
the expected and observed imbalance-factors for each ratio
after 28 cycles of amplification (Table II). Thus the number
ofcycles does not influence the outcome of the PCR reaction
and does not interfere with the possibility of detecting small
differences in allele concentrations.
Detection ofLOH
Ovarian tumours were screened with polymorphic probes in
Southern analysis to select unequivocal cases of LOH. Allele
losses with the RFLP markers D17S58, Dl7S74 and Dl7S4
are shown in Figure 3a. In the tumour, one of the alleles is
always almost completely absent. Three cases of serous
adenocarcinoma of the ovary were selected for analysis of
their cognate paraffin embedded tissues on the basis of ap-
parent loss of heterozygosity: OV16, OV26, OV29a and
OV29b (a primary tumour and a metastasis). In addition
OV19 and OV4 were included, the latter one to examine the
possibility of detecting LOH in archival material (>10 years
of storage).
A sample of 2ftl of the extracted DNA was used as
template in PCR. An estimation by dot-blot hybridisation
with a BLUR8 probe (Figure 4) (not shown for OV19)
indicated that these samples contained between 1 and 70 ng
DNA.
The microsatellite markers 42D6, 46E6 and THRAl were
used because they are flanked by the RFLP markers Dl7S74
and Dl7S4 used in the Southern analysis (Figure 3b). To
verify the results, marker 46E6 was amplified on DNA
isolated from peripheral blood leucocytes and snap-frozen
tissue (Figure 3c). Patients 16 and 26 are homozygous for
this marker (Figure 3b). Patients 29 and 4 are heterozygous
(lanes 29n and 4n) and show clear LOH: a strong intensity
decrease in the tumour lanes of either the lower alleles
(29a,b) or the upper bands (4a,b). Using microsatellite
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Figure 2 a, The behaviour of allelic imbalances during increasing numbers of PCR cycles was studied by mixing a total of 15 ng
DNA from individuals I and II in the ratios 10:0 (lane 1), 9:1 (lane 2), 8:2 (lane 3), 7:3 (lane 4), 6:4 (lane 5), 5:5 (lane 6), 4:6 (lane
7), 3:7 (lane 8), 2:8 (lane 9), 1:9 (lane 10) and 0:10 (lane 11). PCR was carried out for respectively 28, 33 and 36 cycles with the
marker D6S251. Exposure was overnight. At D6S251, person I is homozygous for allele 1, and person II is homozygous for allele
2. b, Intensities of the bands in the indicated windows after 28 cycles of amplification (right panels) were scanned by a laser
densitometer (left panels).LOH IN FRESH AND ARCHIVAL MATERIAL 311
Table II Expected and observed imbalance factors obtained in a titration experi-
ment studying the behaviour of allelic imbalances
Lane 1 2 3 4 5 6 7 8 9 10 11
Exp 00 9.0 4.0 2.3 1.5 1.0 0.7 0.4 0.3 0.1 0.0
Obsa X 8.1 3.4 1.9 1.3 1.0 0.6 0.4 0.3 0.1 0.0
aThe imbalance factor is defined as the ratio of allele intensities in the tumour
sample relative to the ratio of the alleles in normal DNA (Figure 2a; left panel
lane 6).
C
2Qn 28. 29b
Flgure 3 Analysis ofLOH with polymorphic chromsome 17 markers in ovarian tumours. n = normal DNA; a, b = tumour DNA.
Patient identification numbers on the top. a, Southern hybridisation with the probes D17S58 (upper panel), D17S74 (middle panel),
and D17S4 (lower panel). b, PCR with microsatellite markers THRAI (upper panel), 42D6 (middle panel) and 46E6 (lower panel)
on DNA isolated from fixed, embedded tissue. c, PCR with microsatellite marker 46E6 on DNA isolated from blood and fresh
(snap-frozen) tissue.
markers 42D6 and THRAI, OV19 and OV29 show loss of
the upper alleles. However the loss of the upper allele of
OV19 is not complete (lanes 19a,b), due to contamination
with normal DNA.
We conclude that LOH can be detected in DNA isolated
from fixed paraffin embedded tissue, even in DNA extracted
from 10-year-old archival tissue. The observed allele losses
are quite comparable to those obtained with the flanking
RFLPs in Southern analysis. The very low intensity of the
alleles in lane 4n is probably due to the lower amount of
input DNA as verified in the dot-blot hybridisation (Figure
4).
Discussion
Studies on selective loss of genetic material have lead to an
increased understanding of the genetic mechanisms underly-
ing the initiation and progression of a variety of human
malignancies, including retinoblastoma (Cavenee et al., 1983),
Wilms tumour (Koufos et al., 1984), familial adenomatous
polyposis (Solomon et al., 1987) and breast carcinoma
(Devilee et al., 1991). In these studies, LOH or allelic
imbalance was analysed by Southern blot techniques of con-
ventional RFLPs, requiring relatively large amounts of
DNA. The major disadvantage ofconventional RFLPs is the312 N.A. GRUIS et al.
16n 16a 26n 26a 29n 29a 29b 4n 4a 4b
Figure 4 Quantitation of DNA by dot-blot hybridisation with
the BLUR8 probe (overnight exposure), patient numbers and
DNA source are indicated (n = isolated from normal tissue, a or
b = isolated from tumour tissue).
limited heterozygosity, being maximally 50% for a two-allele
marker. The introduction of the polymerase chain reaction
(PCR) using thermostable DNA polymerase made it possible
to use small amounts of input DNA. PCR also enables the
analysis of a new class ofpolymorphisms based on the simple
sequence tandem repeats, especially on the sequence
(dC.dA),.(dG.dT)n (Weber & May, 1989; Smeets et al., 1989;
Tautz, 1989). This group of DNA polymorphisms have col-
lectively been named microsatellites (Litt & Luty, 1989).
Microsatellite markers have already proved to be very useful
in mapping of several genetic disease genes (Hanzlik et al.,
1990; Wijmenga et al., 1990; Bell et al., 1991; Cannon-
Albright et al., 1992) and genome mapping (Jabs et al., 1991;
Rose, 1991). Microsatellite markers show a number of
obvious advantages over Southern blot approaches as they (i)
can be detected by PCR, (ii) are not restricted to telomeric or
centromeric regions, (iii) are multi-allelic, (iv) can be used in
a multiplex PCR (multiple primer sets per PCR reaction) and
(v) need a very small amount of input DNA. Due to relatively
short PCR products to be analysed, results are also obtained
on partially degraded DNA, which is virtually impossible
with Southern techniques.
The use of microsatellite markers in LOH studies has also
recently been demonstrated by Louis et al. (1992) in small
and archival human brain tumour specimens, using several
chromosome 10 microsatellite markers. In our study we have
also successfully applied microsatellite markers in the detec-
tion of loss of heterozygosity in fresh ovarian tumour sam-
ples on chromosome 17q. The results were supported by
conventional Southern blotting with flanking markers. The
involvement of chromosome 17 in the etiology of ovarian
cancer, detected by microsatellite markers was already shown
by Smith et al. (1992). We have modified the method in such
a way that even formalin fixed, paraffin embedded sections
can be investigated for LOH. We detected LOH in archival
ovarian material with several microsatellite markers, even in
tissue which has been fixed more than 10 years ago.
From the titration experiments in our study we conclude
that LOH remains detectable despite a variable number of
amplification cycles and a contamination up to 60% with
normal DNA. This percentage of contamination is dependent
on the genetic mechanism involved in LOH, which may lead
to different allelic ratios in the tumour. Thus a monosomy
would result in a 1:0 ratio, while a recombination event
generates a 2:0 ratio (Cavenee et al., 1983). Indeed, a 4:0
ratio may be achieved if the latter is followed by tetra-
ploidisation, which is thought to be an important step in the
tumourigenesis of breast and ovarian cancer. Obviously, the
detection of a 1:0 allelic ratio is more sensitive to contamina-
tion from normal cells than a 4:0 ratio. If we assume an
arbitrary imbalance factor of 1.3, LOH due to recombination
can principally still be detected despite 80% contaminating
DNA. In our study a somatic recombination event was
simulated in which visually LOH can be detected in the
presence of 60% contaminating DNA. To reduce the chance
of missing LOH, samples with a minimum of 60% tumour
cells should be used.
Although choice of fixative and fixation time can be
critical factors influencing the outcome of PCR amplification
of DNA extracted from paraffin-embedded material (Greer et
al., 1991a; Greer et al., 1991b; Ben Ezra et al., 1991), we
believe that PCR-based microsatellite polymorphisms are
excellent tools in the detection of loss of heterozygosity in
fresh (snap-frozen) as well as in formalin fixed, paraffin
embedded material. The possibility of using fixed, paraffin
embedded material will be particularly valuable in opening
huge pathologic archives for genetic investigation.
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